| __timestamp | Celldex Therapeutics, Inc. | Eli Lilly and Company |
|---|---|---|
| Wednesday, January 1, 2014 | 3586000 | 19615600000 |
| Thursday, January 1, 2015 | 5480000 | 19958700000 |
| Friday, January 1, 2016 | 6786000 | 21222100000 |
| Sunday, January 1, 2017 | 12743000 | 22871300000 |
| Monday, January 1, 2018 | 9538000 | 21493300000 |
| Tuesday, January 1, 2019 | 3573000 | 22319500000 |
| Wednesday, January 1, 2020 | 7418000 | 24539800000 |
| Friday, January 1, 2021 | 4651000 | 28318400000 |
| Saturday, January 1, 2022 | 2357000 | 28541400000 |
| Sunday, January 1, 2023 | 6883000 | 34124100000 |
| Monday, January 1, 2024 | 45042700000 |
Igniting the spark of knowledge
In the dynamic world of pharmaceuticals, Eli Lilly and Company and Celldex Therapeutics, Inc. have charted distinct paths over the past decade. From 2014 to 2023, Eli Lilly's revenue surged by approximately 74%, reaching a peak of $34 billion in 2023. This growth underscores its robust market presence and strategic innovations.
Conversely, Celldex Therapeutics, Inc. experienced a more volatile journey. Despite a significant spike in 2017, where revenue nearly doubled, the company faced fluctuations, with 2022 marking a low point. However, a promising rebound in 2023 saw revenues climb by nearly 192% from the previous year.
This comparison highlights the contrasting trajectories of a pharmaceutical giant and a smaller biotech firm, offering insights into their strategic maneuvers and market adaptability.
Who Generates More Revenue? Eli Lilly and Company or Alnylam Pharmaceuticals, Inc.
Eli Lilly and Company vs Genmab A/S: Examining Key Revenue Metrics
Revenue Insights: Eli Lilly and Company and Alkermes plc Performance Compared
Eli Lilly and Company or Vericel Corporation: Who Leads in Yearly Revenue?
Annual Revenue Comparison: Eli Lilly and Company vs ImmunityBio, Inc.
Breaking Down Revenue Trends: Eli Lilly and Company vs Supernus Pharmaceuticals, Inc.
Breaking Down Revenue Trends: Eli Lilly and Company vs BioCryst Pharmaceuticals, Inc.
Eli Lilly and Company vs Viridian Therapeutics, Inc.: Examining Key Revenue Metrics
Revenue Showdown: AbbVie Inc. vs Celldex Therapeutics, Inc.
Comparing Revenue Performance: Teva Pharmaceutical Industries Limited or Celldex Therapeutics, Inc.?
Breaking Down Revenue Trends: Mesoblast Limited vs Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. vs MiMedx Group, Inc.: Annual Revenue Growth Compared